354 related articles for article (PubMed ID: 28648755)
41. Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
Qiao EQ; Yang HJ; Zhang XP
J Zhejiang Univ Sci B; 2020 Jun; 21(6):495-508. PubMed ID: 32478495
[TBL] [Abstract][Full Text] [Related]
42. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
43. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
44. Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion.
Li Z; Li J; Ji D; Leng K; Xu Y; Huang L; Jiang X; Cui Y
Gene; 2018 Mar; 645():131-136. PubMed ID: 29246536
[TBL] [Abstract][Full Text] [Related]
45. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
[TBL] [Abstract][Full Text] [Related]
46. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma.
Ma KX; Wang HJ; Li XR; Li T; Su G; Yang P; Wu JW
Tumour Biol; 2015 May; 36(5):3355-9. PubMed ID: 25613066
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of E-cadherin expression by lnc-RNA H19 to facilitate bladder cancer metastasis.
Zhu Z; Xu L; Wan Y; Zhou J; Fu D; Chao H; Bao K; Zeng T
Cancer Biomark; 2018; 22(2):275-281. PubMed ID: 29614625
[TBL] [Abstract][Full Text] [Related]
48. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
Pan GF; Zhou XF; Zhao JP
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
[No Abstract] [Full Text] [Related]
49. Expression and correlation of MALAT1 and SOX9 in non-small cell lung cancer.
Chen W; Zhao W; Chen S; Zhang L; Guo Z; Wang L; Wang J; Wan Z; Hong Y; Yu L
Clin Respir J; 2018 Jul; 12(7):2284-2291. PubMed ID: 29896925
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of long non-coding RNA MALAT1 in cancer patients.
Wu Y; Lu W; Xu J; Shi Y; Zhang H; Xia D
Tumour Biol; 2016 Jan; 37(1):897-903. PubMed ID: 26254614
[TBL] [Abstract][Full Text] [Related]
51. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
52. The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1.
Hou Z; Xu X; Zhou L; Fu X; Tao S; Zhou J; Tan D; Liu S
Tumour Biol; 2017 Jul; 39(7):1010428317718135. PubMed ID: 28720061
[TBL] [Abstract][Full Text] [Related]
53. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
55. Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma.
Rioja J; Bandrés E; Rosell Costa D; Rincón A; López I; Zudaire Bergera JJ; García Foncillas J; Gil MJ; Panizo A; Plaza L; Rioja LA; Berián Polo JM
BJU Int; 2011 Jun; 107(11):1833-8. PubMed ID: 20840328
[TBL] [Abstract][Full Text] [Related]
56. External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.
Ramírez-Backhaus M; Fernández-Serra A; Rubio-Briones J; Cruz Garcia P; Calatrava A; Garcia Casado Z; Casanova Salas I; Rubio L; Solsona E; López-Guerrero JA
Actas Urol Esp; 2015 Oct; 39(8):473-81. PubMed ID: 25920992
[TBL] [Abstract][Full Text] [Related]
57. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value.
Liu J; Dong H; Yang Y; Qian Y; Liu J; Li Z; Guan H; Chen Z; Li C; Zhang K; Zhang Q; Cao W; Lv J
Future Oncol; 2018 Dec; 14(29):3015-3022. PubMed ID: 29987950
[TBL] [Abstract][Full Text] [Related]
59. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
60. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
